SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-033243
Filing Date
2021-02-09
Accepted
2021-02-09 06:35:45
Documents
65
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q d125513d10q.htm 10-Q 488586
2 EX-31.1 d125513dex311.htm EX-31.1 10560
3 EX-31.2 d125513dex312.htm EX-31.2 10675
4 EX-32.1 d125513dex321.htm EX-32.1 3133
5 EX-32.2 d125513dex322.htm EX-32.2 2976
  Complete submission text file 0001193125-21-033243.txt   3692963

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bntc-20201231.xml EX-101.INS 898589
7 XBRL TAXONOMY EXTENSION SCHEMA bntc-20201231.xsd EX-101.SCH 34375
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bntc-20201231_cal.xml EX-101.CAL 36203
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bntc-20201231_def.xml EX-101.DEF 96621
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bntc-20201231_lab.xml EX-101.LAB 267242
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bntc-20201231_pre.xml EX-101.PRE 204607
Mailing Address LEVEL 14, 114 WILLIAM ST MELBOURNE, VIC C3 3000
Business Address LEVEL 14, 114 WILLIAM ST MELBOURNE, VIC C3 3000 61(0)3 8692-7222
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39267 | Film No.: 21603880
SIC: 2834 Pharmaceutical Preparations